GatePass Capital’s CareDx CDNA Stock Holding History

GatePass Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$195K	–	148
2025 Q2	$195K	Buy	+10,000	New	+$178K	0.13%	116

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GatePass Capital's CDNA Position: Q3 2025 in Review

GatePass Capital sold out of CareDx (CDNA) in Q3 2025, closing a stake of 10,000 shares — an estimated $195K sold.

GatePass Capital first reported a position in CDNA in Q2 2025 and held it in 1 quarter. The position peaked at $195K in Q2 2025. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

GatePass Capital reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
GatePass Capital sold 10,000 CareDx shares in Q3 2025, an estimated $195K.
GatePass Capital first reported a position in CareDx in Q2 2025 and held it in 1 quarter.
GatePass Capital's CareDx position peaked at $195K in Q2 2025.
187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on GatePass Capital's 13F filing for Q3 2025, filed 29 Oct 2025.